Surplus Management Of Research And Development Expenditures Of Pharmaceutical Companies Was Found And Suppressed

Since the eighteen years,we have made great efforts to promote innovative ideas.On the macro level,we need to innovate,innovate and innovate in the process of reform and development.From the microscopic point of view,in the increasingly fierce market economy,our enterprises need to constantly innovate products,innovative technology.Innovation requires research and development,research and development needs of R & D investment.As one of the reactors of our economy,accounting needs to be confirmed and measured.Because China is now using R & D expenditure conditional capital recognition model,may bring the earnings management space.The managers of enterprises will increase the profits and beautify the financial reports with the aid of accounting policies.It is difficult to identify the audit department and the regulatory authorities of this approach to increase profits,optimize the company's earnings management.Therefore,this paper attempts to use the economic value added momentum to curb earnings management,so that investors get the information is not adding the manipulated data and information.In this paper,a case study of a pharmaceutical company,because the pharmaceutical R & D investment,research and development needs.Because of this,it is necessary to explore the earnings management of the accounting policy choice of R & D expenditures.In this paper,the principal-agent theory and asymmetric information theory are used as the theoretical basis of the study,and the data of the case is a case study based on the annual report and related economic data.Firstly,this paper describes the background of the research,in the environment of innovation,we must pay attention to the related research and development of accounting activities.In the case analysis,the use of a typical model:ask questions,analyze problems,solve the problem in three steps.The companies will use the means of earnings management in R & D expenditure accounting;analysis of enterprise use accounting policy selection problems of earnings management;economic value added by the momentum measurement index to suppress such situation again.This paper finally puts forward a relevant conclusion,and analyze their lack of appears in the research process,need after authors and experts and scholars on the in-depth study and discussion about the earnings management of R & D expenditures.